**Core Concept**
Serum acid phosphatase is a biomarker primarily released by prostate tissue, especially during prostate enlargement or malignancy. It is elevated in benign prostatic hyperplasia (BPH) and prostate cancer, making it useful in evaluating urinary retention due to prostate pathology.

**Why the Correct Answer is Right**
Serum acid phosphatase is secreted by prostate epithelial cells and increases in concentration when there is prostate enlargement or neoplasia. In a 70-year-old man presenting with urinary retention and back pain, prostate pathology—such as BPH or prostate cancer—is a leading cause. Acid phosphatase is more specific than other markers for prostate origin, and its elevation helps differentiate between benign and malignant causes. It is particularly useful in older men with obstructive urological symptoms.

**Why Each Wrong Option is Incorrect**
Option B: Serum calcium is not specific to prostate disease and is more relevant in hyperparathyroidism or malignancy, but it does not help diagnose prostate-related urinary retention.
Option C: Serum alkaline phosphatase is elevated in liver or bone diseases, not specifically in prostate pathology.
Option D: Serum electrophoresis detects protein abnormalities (e.g., multiple myeloma), which are not directly linked to urinary retention or prostate disease.

**Clinical Pearl / High-Yield Fact**
In elderly men with urinary retention, serum acid phosphatase is a key initial test to evaluate prostate pathology—especially before imaging or biopsy. It is a classic screening tool for prostate disease, though now largely superseded by PSA.

✓ Correct Answer: A. Serum acid phosphatase